SEC Releases Crowd Funding Rules for Non-Accredited Investors Under the JOBS Act.

On October 25, 2013, The Securities and Exchange Commission (SEC) released the Proposed Rules to govern the implementation of crowd funding by non-accredited investors under the JOBS Act.   Comments will be open for a 90 day  public comment period from the date that the proposed regs appear on the Federal Register. (As of this writing, the proposed regs have not yet been posted.) Continue reading

Convoy Therapeutics and Hugel Enter Co-Development Partnership

Convoy Therapeutics, a late pre-approval stage biotechnology company using its proprietary transdermal molecule delivery platform to enhance penetration of large molecules, and retention of small molecules into skin and cells announced today they have entered into a multi-million dollar co-development partnership for exclusive South Korean market rights to Convoy’s Khalay HATM featuring HylaRegenesisTM technology.Continue reading

Mission3 Ranks 823 on Inc. 5000 List of Fast Growing Private Companies



Phoenix, AZ – September 5, 2013 – Mission3, visionaries in cloud-based software for the Life Sciences industry, today announced it has earned the rank as the 823 fastest growing private company on the Inc. 5000 2013 list.  Mission3 realized a 3 year revenue growth of 546%.  This list represents the most comprehensive look at the most important segment of the economy – America’s independent entrepreneurs. Continue reading

2013 BIO Fly In – AZBio’s update from Capitol Hill

Last week, over 200 leaders from across the nation visited Washington D.C. to meet with their Congressional delegations and share ideas with our nation’s leaders on the importance of our bioindustry and on the issues that are key to moving innovation forward and providing access to these life sustaining and life saving innovations.Continue reading